NEW YORK – Customers are beginning to line up for Inscripta's Onyx Digital Genome Engineering platform, launched in October.
The first of the fully automated benchtop instruments, designed to enable genome editing at unprecedented scale, will go to Jef Boeke of New York University in the first half of this year. "It looks very promising," said Boeke, who participated in an early-access program. The system "allowed us to look at thousands of changes in parallel," he said.